Previous 10 | Next 10 |
Karuna Therapeutics (NASDAQ: KRTX ) +80% on positive KarXT data . More news on: Karuna Therapeutics, Inc., Eros International Plc, Capstone Turbine Corporation, Stocks on the move, Read more ...
Ultra-thinly traded nano cap Caladrius Biosciences (NASDAQ: CLBS ) is up 14% premarket on increased volume, albeit on turnover of only 25K shares, in reaction to results from a proof-of-concept study, ESCaPE-CMD, evaluating autologous CD34+ cell therapy CLBS16 in patients with ...
Single administration of CLBS16 durably improves heart function and symptoms with no cell-related adverse events CLBS16 cell therapy shows promise as a significant advancement in treatment of Coronary Microvascular Dysfunction (CMD), a condition that disproportionately afflicts women ...
Caladrius Biosciences, Inc. (CLBS) Q3 2019 Earnings Conference Call November 6, 2019 4:30 PM ET Company Participants John Menditto – Vice President of Investor Relations and Corporate Communications David Mazzo – President and Chief Executive Officer Joseph Talamo &...
Caladrius Biosciences (NASDAQ: CLBS ): Q3 GAAP EPS of -$0.47. Cash & equivalents of $29.2M Shares -1.4% . Press Release More news on: Caladrius Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, ,
BASKING RIDGE, N.J., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company pioneering advancements of cell therapies in select cardiovascular an...
BASKING RIDGE, N.J., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company pioneering advancements of cell therapies in select cardiovascular an...
Gainers : Ra Pharmaceuticals, Inc. (NASDAQ: RARX ) +100% . OncoSec Medical Incorporated (NASDAQ: ONCS ) +34% . ProPetro Holding Corp. (NYSE: PUMP ) +22% . Mereo BioPharma Group plc (NASDAQ: MREO ) +21% . Bed Bath & Beyond (NASDAQ: BBBY ) +20% . Caladrius Biosciences (NASDAQ: CLBS ...
BASKING RIDGE, N.J., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company pioneering advancements of cell therapies in select cardiovascular an...
The following slide deck was published by Caladrius Biosciences, Inc. in conjunction with this Read more ...
News, Short Squeeze, Breakout and More Instantly...
Caladrius Biosciences Inc. Company Name:
CLBS Stock Symbol:
NASDAQ Market:
Caladrius Biosciences Inc. Website:
BASKING RIDGE, N.J., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), announced today that, based upon the final vote count certified by the independent inspector of elections for the annual meeting of ...
NEW YORK, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming Life Sciences Virtual Investor Conference to be held on September 15 th . Individual investors, institutional ...
BASKING RIDGE, N.J., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company developing innovative therapies designed to treat or reverse disease, today announced tha...